Deutsche Bank Ag\ Gilead Sciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 8,529,057 shares of GILD stock, worth $801 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

8,529,057

Previous 7,207,002 18.34%

Holding current value

$801 Million

Previous $494 Million 44.58%

% of portfolio

0.3%

Previous 0.23%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $88 Million - $111 Million	1,322,055 Added 18.34%	8,529,057 $715 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $18.5 Million - $21.4 Million	-293,366 Reduced 3.91%	7,207,002 $494 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $13.7 Million - $16.7 Million	-191,049 Reduced 2.48%	7,500,368 $549 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $53.2 Million - $60.3 Million	725,825 Added 10.42%	7,691,417 $623 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $86.3 Million - $94.2 Million	-1,167,311 Reduced 14.35%	6,965,592 $522 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $81.2 Million - $92.6 Million	-1,068,098 Reduced 11.61%	8,132,903 $627 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $63.5 Million - $72.4 Million	821,730 Added 9.81%	9,201,001 $763 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $14.1 Million - $20.3 Million	-226,993 Reduced 2.64%	8,379,271 $719 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $20.5 Million - $23.4 Million	-344,082 Reduced 3.84%	8,606,264 $531 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $43.1 Million - $48.5 Million	746,049 Added 9.09%	8,950,346 $553 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $38 Million - $47.6 Million	656,020 Added 8.69%	8,204,297 $488 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $1.95 Million - $2.21 Million	-30,077 Reduced 0.4%	7,548,277 $548 Million
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $28.1 Million - $30.3 Million	-415,349 Reduced 5.2%	7,578,354 $529 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $17.9 Million - $19.6 Million	282,231 Added 3.66%	7,993,703 $550 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $27.9 Million - $31.8 Million	464,519 Added 6.41%	7,711,472 $498 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $14.6 Million - $16.7 Million	-258,256 Reduced 3.44%	7,246,953 $422 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $15.3 Million - $19.2 Million	245,583 Added 3.38%	7,505,209 $474 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $50.3 Million - $58.4 Million	-695,463 Reduced 8.74%	7,259,626 $559 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $172 Million - $221 Million	-2,749,763 Reduced 25.69%	7,955,089 $595 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $6.9 Million - $7.59 Million	-112,043 Reduced 1.04%	10,704,852 $696 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $62.4 Million - $68.9 Million	-998,511 Reduced 8.45%	10,816,895 $686 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $45.1 Million - $50.6 Million	-728,819 Reduced 5.81%	11,815,406 $798 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $74.8 Million - $83.8 Million	1,195,589 Added 10.54%	12,544,225 $815 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $61.9 Million - $80.8 Million	-1,022,538 Reduced 8.27%	11,348,636 $710 Million
Q3 2018 Dec 21, 2021	BUY	$71.28 - $78.92 $267 Million - $295 Million	3,741,069 Added 43.35%	12,371,174 $955 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $185 Million - $204 Million	-2,588,711 Reduced 23.07%	8,630,105 $666 Million
Q2 2018 Apr 21, 2020	BUY	$64.88 - $75.68 $111 Million - $129 Million	1,707,196 Added 17.95%	11,218,816 $795 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $188 Million - $220 Million	-2,900,384 Reduced 23.37%	9,511,620 $674 Million
Q1 2018 Oct 18, 2019	BUY	$72.84 - $88.8 $184 Million - $224 Million	2,524,643 Added 25.53%	12,412,004 $936 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $48.5 Million - $59.2 Million	-666,377 Reduced 6.31%	9,887,361 $745 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $20.2 Million - $23.7 Million	-283,466 Reduced 2.62%	10,553,738 $756 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $781 Million - $926 Million	10,837,204	10,837,204 $878 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account